FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

2,571 letters match. Newest first.

  1. DO&CO Aktiengesellschaft/DO&CO, Inc.

    DO&CO airline catering facilities in New York and Michigan had repeated Listeria monocytogenes contamination and sanitation failures.

    High risk
  2. Hearthy Foods, Inc.

    FDA cited Hearthy Foods after an inspection for CGMP violations in RTE whey protein and dietary supplements, including allergen and pest issues.

    High risk
  3. South Bay Cold Storage & Handling, Inc.

    FDA warned South Bay Cold Storage & Handling that its seafood safety plans and sanitation were inadequate for crab, smoked salmon and scombroid fish.

    High risk
  4. Naumes, Inc.

    FDA warned Naumes, Inc. that its pears may have been contaminated with filth after an inspection found produce-safety violations.

    High risk
  5. Min Jiang Food Store Inc dba Koi Koi Trading

    FDA found Listeria on food-contact surfaces at Koi Koi Trading's ready-to-eat seafood plant and cites seafood HACCP failures.

    High risk
  6. RSV Pita, Inc. DBA Pita Pan Bakery

    FDA warns Pita Pan Bakery that ready-to-eat pita, bagels and challah were made under insanitary conditions and had undeclared allergens.

    High risk
  7. Aaa International Seafood Corp.

    Aaa International Seafood Corp. fresh tuna and salmon were adulterated due to seafood HACCP and importer verification failures.

    High risk
  8. Lexia LLC

    FDA cited Lexia for manufacturing violations in an OTC topical pain relief drug, including missing release and component testing.

    High risk
  9. Intas Pharmaceuticals Limited

    FDA warns Intas Pharmaceuticals' Dehradun, India plant over weak out-of-spec investigations and untracked batch-record edits for its tablets.

    High risk
  10. Nupack Inc.

    FDA warned Nupack Inc. that its dietary supplements were unapproved drugs and made without required manufacturing-practice records.

    High risk
  11. Daily Manufacturing Solutions Inc.

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  12. nicoprof.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  13. Par Health USA, LLC & Endo USA, Inc.

    FDA cited Par Health USA/Endo USA’s Rochester plant for sterile injectable contamination-control, media fill, and visual inspection failures after an October 2025 inspection.

    High risk
  14. New Life Pharma LLC

    New Life Pharma made unapproved semaglutide and tirzepatide sterile vials without sterility controls and refused FDA access to some areas.

    High risk
  15. UCSF Radiopharmaceutical Facility

    FDA cited UCSF Radiopharmaceutical Facility for inadequate sterility failure investigations and environmental monitoring of sterile drug manufacturing.

    High risk
  16. shopcalismokes.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  17. vapepengood.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  18. Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

    FDA found filthy conditions and falsified records at Chinese drug maker Xiamen Kang Zhongyuan; cough drops recalled, imports blocked.

    High risk
  19. RC Outsourcing, LLC

    FDA warned outsourcing facility RC Outsourcing of Lowellville, Ohio, that its sterile drugs were made under insanitary conditions that risk contamination.

    High risk
  20. Thrive Health and Wellness, LLC dba Thrive Health Solutions

    FDA warned Thrive Health and Wellness, a Colorado repackager, that sterile drugs were made in unsanitary conditions and sold without approval.

    High risk
  21. Apollo Care, LLC

    FDA cited Apollo Care for insanitary conditions and quality failures in sterile compounded drugs, including a sterility-assurance recall.

    High risk
  22. Medical Products Laboratories, Inc.

    Medical Products Laboratories was cited for manufacturing failures and selling unapproved prescription skin drugs.

    High risk
  23. Smart Vending Services, LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  24. mohawksmoke.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  25. Purolea Cosmetics Lab

    Purolea Cosmetics Lab drug products were adulterated by insanitary conditions and manufacturing failures, and two Dermveda products are unapproved new drugs.

    High risk
  26. Schlechter Farms Inc.

    FDA found bird feces throughout Schlechter Farms' Oregon onion packing shed, adulterating onions and repeating 2023 violations.

    High risk
  27. Ocean Group Inc.

    FDA found Listeria monocytogenes and seafood HACCP sanitation violations at Ocean Group's ready-to-eat salmon and tuna facilities.

    High risk
  28. Barcelona Nut Company Inc.

    Barcelona Nut Company in Baltimore found rodent and insect contamination and allergen cross-contact in ready-to-eat nuts and seeds.

    High risk
  29. Global Tobacco, LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  30. Medline Industries, LP

    Medline's Glen Falls, NY plant made angiographic syringes and kits under flawed CAPA, cleaning and design verification controls, FDA says.

    High risk
  31. buydeltas.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  32. Henan Lvyuan Pharmaceutical Co. Ltd.

    FDA warns Henan Lvyuan Pharmaceutical over CGMP failures at its API plant, including water leaks and incomplete batch records.

    High risk
  33. Microbiological Testing & Consulting, LLC

    FDA warned contract testing lab Microbiological Testing & Consulting over CGMP violations in drug product microbiological testing.

    High risk
  34. Physitemp Instruments, LLC

    FDA says Physitemp sold clinical thermometers and temperature probes without FDA clearance and with unvalidated sterilization and welding.

    High risk
  35. matesbrand.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  36. Yangzhou H&R Plastic Daily Chemical Co., Ltd.

    Yangzhou H&R Plastic Daily Chemical, a Chinese contract manufacturer, lacked release testing and CGMP controls for its OTC drug.

    High risk
  37. 4U Health

    FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.

    High risk
  38. Longhorn Vaccines and Diagnostics LLC

    Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.

    High risk
  39. IsoTis OrthoBiologics, Inc.

    IsoTis OrthoBiologics in Irvine, CA failed to properly fix and assess possible particulate contamination in its Accell bone filler devices, FDA says.

    High risk
  40. Patcos Cosmetics Pvt. Ltd.

    Patcos Cosmetics, an Indian OTC drug manufacturer, was cited for insanitary conditions and CGMP violations after a 2025 FDA inspection.

    High risk
  41. OraLabs, Inc.

    FDA warned OraLabs, an OTC drugmaker in Parker, Colorado, that it skipped microbial release testing and dismissed contamination findings.

    High risk
  42. Flowchem Pharma Private Limited

    FDA warned India's Flowchem Pharma over dirty API equipment, exposed materials and untested impurities, and blocked its drug imports.

    High risk
  43. JZ Wholesale, Inc.

    FDA warned JZ Wholesale after finding widespread rodent and insect contamination in food at its Fort Smith, Arkansas warehouse.

    High risk
  44. prilla.com/us

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  45. Feng Foods Trading Inc.

    FDA warns Feng Foods Trading over failure to verify imported seafood was processed under seafood HACCP rules.

    High risk
  46. Apothecary Pharma, LLC

    FDA warns Apothecary Pharma, an outsourcing facility, that its sterile compounded drugs were made under insanitary conditions.

    High risk
  47. Avertix Medical, Inc.

    FDA warns Avertix Medical over Guardian implantable cardiac event detector quality violations and late injury reports.

    High risk
  48. SSS AUSTAR LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  49. Simtra BioPharma Solutions

    FDA found contamination risks in Simtra's sterile drug manufacturing in Germany, including microbial recoveries, failed isolator tests, and inadequate decontamination.

    High risk
  50. Tentamus India Private Limited

    FDA warned India-based contract testing lab Tentamus over destroyed and backdated lab records and limited inspection access.

    High risk